Javier Escaned1*, MD, PhD; Adrian Banning2, MD, PhD; Vasim Farooq3, MBChB, MRCP, PhD; Mauro Echavarria-Pinto1, MD; Yoshinobu Onuma4, MD, PhD; Nicola Ryan1, MB, BCh; Rafael Cavalcante5, MD, PhD; Carlos M. Campos5,6, MD; Bojan M. Stanetic5,7, MD; Yuki Ishibashi5, MD, PhD; Pannipa Suwannasom5,8, MD; Arie-Pieter Kappetein5, MD, PhD; David Taggart2, MD; Marie-Angèle Morel4, BSc; Gerrit-Anne van Es4, PhD; Patrick W. Serruys9, MD, PhD; on behalf of the SYNTAX II Study Group
1. Hospital Clinico San Carlos/Faculty of Medicine Complutense University, Madrid, Spain; 2. John Radcliffe Hospital, Oxford, United Kingdom; 3. Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester and